Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
NOVO B:CPH since
announced
Transaction
value
Cardior Pharmaceuticals GmbHAnnounced25 Mar 202425 Mar 2024Announced-1.10%1.11bn
Catalent Inc-Manufacturing Sites Portfolio(3)Announced05 Feb 202405 Feb 2024Announced12.29%--
Elan Drug Technologies (DNU>16Sep2011 now 01781A)Announced14 Dec 202314 Dec 2023Announced30.60%92.42m
Embark Biotech ApSDeal completed29 Aug 202329 Aug 2023Deal completed35.72%16.22m
Inversago Pharma IncDeal completed10 Aug 202310 Aug 2023Deal completed38.90%1.08bn
Data delayed at least 15 minutes, as of Apr 26 2024 12:12 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.